repurposing semaglutide and liraglutide for alcohol use disorder Effects of glucagon-like peptide-1 receptor agonists on consumption: a systematic review meta-analysis Five Addiction Treatments That Might

Blood in the urine, frothy urine, or significantly reduced urine output are never normal side effects of weight loss medication and require prompt GP assessment

With their cross-biological-system effects, GLP-1s may prove helpful in reducing the impact of some of these factors

GLP-1 agonists are generally considered low risk for hypoglycemia because their insulinotropic effects are glucose-dependent, tapering off as serum glucose approaches euglycemia

This psychological preference is valid and can influence adherence

Understanding your predispositions in FTO, MC4R, and GLP-1 receptor pathways may help your provider anticipate tolerability and efficacy patterns, though genetics do not predict exact response

What this means for underwriting GLP1s demand a shift in mindset